US Department of Defense Tuberous Sclerosis Complex Research Program Opens
The US Department of Defense (DoD) Congressionally Directed Medical Research Program (CDMRP) was established in 1992 and is one of the largest funders of clinical research in the United States.
The aim of the Tuberous Sclerosis Complex Research Program (TSCRP) is to fund exploratory, pioneering and transformative science that promotes discoveries in Tuberous Sclerosis Complex (TSC), from mechanistic insights to clinical application, by supporting new ideas and investigators for the benefit of Service members, their beneficiaries, and the American public.
All organisations, including international organisations, are eligible to apply to the programme.
The following Awards are open to application:
Hypothesis Development Award
This Award supports the initial exploration of innovative, high-risk, high-gain, and potentially ground-breaking concepts in the TSC research field.
Eligible applicants are investigators at all academic levels (or equivalent), including postdoctoral fellows.
The maximum funding is $150,000 for direct costs. The maximum duration is two years.
Idea Development Award
The Award supports ideas that have the potential to yield high-impact findings and new avenues of investigation.
Eligible applicants are:
Established Investigators: independent investigators at or above the level of Assistant Professor (or equivalent).
New Investigators: independent investigators at or below the level of Assistant Professor (or equivalent) or Established Investigators in an area other than TSC at or above the level of Assistant Professor seeking to transition to a career in TSC.
The maximum funding is $450,000 for direct costs. The maximum duration is three years.
Clinical Translational Research Award
This Award supports forward and/or reverse clinical/translational studies that have a reciprocal flow of ideas and information between basic and clinical science and have the potential to improve the diagnosis, prognosis, or treatment of TSC.
Eligible applicants are independent Investigators at or above the level of Assistant Professor (or equivalent).
The maximum funding is $600,000 for direct costs. The maximum duration is three years.
The deadline for Letters of Intent, for all Awards, is 18 April 2019.
More information about this research funding opportunity and the application process is available on the RESEARCHconnect funding information platform. RESEARCHconnect provides up-to-the minute content, insight and analysis on research funding news and policy. To find out more about how RESEARCHconnect can keep you in the know, and subscription fees, contact us today.